Literature DB >> 31186297

Association of Serum Retinol-Binding Protein 4 Levels and the Risk of Incident Type 2 Diabetes in Subjects With Prediabetes.

Jiahua Fan1, Songping Yin1, Diaozhu Lin2, Yangqing Liu1, Nixuan Chen1, Xinxiu Bai1, Qiuyi Ke1, Jia Shen1, Lili You2, Xiuhong Lin3, Feng Li2, Fengyi He3, Li Yan2, Chaogang Chen4, Min Xia5.   

Abstract

OBJECTIVE: To explore the association of serum retinol-binding protein 4 (RBP4) levels and risk for the development of type 2 diabetes in individuals with prediabetes. RESEARCH DESIGN AND METHODS: A population-based prospective study was conducted among 1,011 Chinese participants with prediabetes (average age 55.6 ± 7.2 years). Incident type 2 diabetes was diagnosed according to the American Diabetes Association 2010 criteria. Serum RBP4 levels were measured using a commercially available ELISA. We analyzed the association of serum RBP4 levels with the risk of incident type 2 diabetes using the Cox proportional hazards model.
RESULTS: During a median follow-up period of 3.1 years, 153 participants developed incident type 2 diabetes. A U-shaped association was observed between serum RBP4 levels and the risk of incident type 2 diabetes, with the lowest risk in the RBP4 range of 31-55 μg/mL. Multivariate Cox regression model analysis showed that serum RBP4 levels <31 μg/mL and RBP4 levels >55 μg/mL were associated with an increased risk of incident type 2 diabetes. The adjusted hazard ratios (95% CI) were 2.01 (1.31-3.09) and 1.97 (1.32-2.93), respectively, after adjusting for age, sex, BMI, waist circumference, γ-glutamyltransferase, HOMA of insulin resistance index, fasting plasma glucose, 2-h plasma glucose, and glycated hemoglobin (HbA1c) levels.
CONCLUSIONS: A U-shaped relationship exists between serum RBP4 levels and the risk of incident type 2 diabetes in subjects with prediabetes.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31186297     DOI: 10.2337/dc19-0265

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

1.  Comparative Evaluation of Chiglitazar and Sitagliptin on the Levels of Retinol-Binding Protein 4 and Its Correlation With Insulin Resistance in Patients With Type 2 Diabetes.

Authors:  Yunting Zhou; Huiying Wang; Yuming Wang; Xiaohua Xu; Fengfei Li; Junming Zhou; Ting Shan; Rong Huang; Tingting Cai; Xiaomei Liu; Xiaofei Su; Huiqin Li; Jianhua Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-25       Impact factor: 6.055

Review 2.  Blood retinol and retinol-binding protein concentrations are associated with diabetes: a systematic review and meta-analysis of observational studies.

Authors:  Jialin Lu; Dandan Wang; Baolan Ma; Xiaochun Gai; Xiao Kang; Jinyu Wang; Ke Xiong
Journal:  Eur J Nutr       Date:  2022-03-23       Impact factor: 4.865

Review 3.  Is the Retinol-Binding Protein 4 a Possible Risk Factor for Cardiovascular Diseases in Obesity?

Authors:  Anna Maria Rychter; Marzena Skrzypczak-Zielińska; Aleksandra Zielińska; Piotr Eder; Eliana B Souto; Agnieszka Zawada; Alicja Ewa Ratajczak; Agnieszka Dobrowolska; Iwona Krela-Kaźmierczak
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

4.  Hepatokine Pregnancy Zone Protein Governs the Diet-Induced Thermogenesis Through Activating Brown Adipose Tissue.

Authors:  Jun Lin; Xiaoxiao Jiang; Meng Dong; Xiaomeng Liu; Qiwei Shen; Yuanyuan Huang; Hanlin Zhang; Rongcai Ye; Huiqiao Zhou; Chunlong Yan; Shouli Yuan; Xiangnan Wu; Li Chen; Yanfang Wang; Min He; Yi Tao; Zhaoyun Zhang; Wanzhu Jin
Journal:  Adv Sci (Weinh)       Date:  2021-09-13       Impact factor: 16.806

5.  Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin.

Authors:  Kuppan Gokulakrishnan; Gautam Kumar Pandey; Chandrakumar Sathishkumar; Saravanakumar Sundararajan; Prabhu Durairaj; Nagaraj Manickam; Viswanathan Mohan; Muthuswamy Balasubramanyam
Journal:  Mol Biol Rep       Date:  2021-05-26       Impact factor: 2.316

6.  Effect of Lifestyle Intervention in the Concentration of Adipoquines and Branched Chain Amino Acids in Subjects with High Risk of Developing Type 2 Diabetes: Feel4Diabetes Study.

Authors:  Itziar Lamiquiz-Moneo; Ana M Bea; Cristian Palacios-Pérez; Pilar De Miguel-Etayo; Esther M González-Gil; Chuan López-Ariño; Fernando Civeira; Luis A Moreno; Rocio Mateo-Gallego
Journal:  Cells       Date:  2020-03-12       Impact factor: 6.600

7.  The Role of Circulating RBP4 in the Type 2 Diabetes Patients with Kidney Diseases: A Systematic Review and Meta-Analysis.

Authors:  Li Zhang; Yan-Li Cheng; Shuai Xue; Zhong-Gao Xu
Journal:  Dis Markers       Date:  2020-10-02       Impact factor: 3.434

Review 8.  Vitamin A and Its Multi-Effects on Pancreas: Recent Advances and Prospects.

Authors:  Yunting Zhou; Huiying Wang; Junming Zhou; Shanhu Qiu; Tingting Cai; Huiqin Li; Ziyang Shen; Yun Hu; Bo Ding; Menghui Luo; Rong Huang; Rengna Yan; Wei Xu; Cong He; Yumin Zhang; Fengfei Li; Zilin Sun; Jianhua Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-18       Impact factor: 5.555

9.  RBP4 Is Associated With Insulin Resistance in Hyperuricemia-Induced Rats and Patients With Hyperuricemia.

Authors:  Chan Liu; Xiao-Rong Zhou; Mu-Yao Ye; Xiang-Qing Xu; Yu-Wei Zhang; Hong Liu; Xian-Zhe Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

10.  Serum levels of retinol-binding protein 4 and the risk of non-small cell lung cancer: A case-control study.

Authors:  Xiaoping Hu; Wenjun Huang; Feng Wang; Yifei Dai; Xiaocong Hu; Daoyuan Yue; Shaomin Wang
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.